RICKY SHAPIRO: Open Payments
NPI 1457330425 · PARK RIDGE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,023 in 45 payments from 9 companies in 2025. Trend: 2023 $222 · 2024 $508 · 2025 $1,023
Food & beverage: $1,023
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $248 |
| AstraZeneca Pharmaceuticals LP | 7 | $223 |
| GENZYME CORPORATION | 5 | $122 |
| CSL Behring | 4 | $119 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $112 |
| Regeneron Healthcare Solutions, Inc. | 4 | $93 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| Genentech USA, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $15 |
Products named: DUPIXENT, AIRSUPRA, Rhapsido, NEFFY, Hizentra, NUCALA, FASENRA, BREZTRI.
Industry payments across IL — which companies pay providers there.
